[Measurement of sphingosine 1-phosphate as a biomarker of atherosclerosis]

Rinsho Byori. 2007 Apr;55(4):358-62.
[Article in Japanese]

Abstract

Sphingosine 1-phosphate (S1P) is concentrated in lipoprotein, especially high density lipoprotein (HDL), in plasma. We characterized the role of HDL-associated S1P in HDL-induced anti-atherogenic effects. HDL-associated S1P mediated HDL-induced stimulation of proliferation, migration and inhibition of apoptosis through S1P specific receptors S1P1 and/or S1P3 in endothelial cells. On the other hand, HDL-induced nitric oxide production and inhibition of adhesion molecule expression were mediated by two pathways, i.e, HDL-associated apoprotein A-I, A-II/SR-BI and S1P/S1P receptors in endothelial cells. Thus, in endothelial cells, HDL-associated S1P is a key player of HDL-induced anti-atherogenic effects.

Publication types

  • English Abstract
  • Review

MeSH terms

  • Atherosclerosis / blood*
  • Biomarkers / blood*
  • Endothelial Cells / physiology
  • Humans
  • Lipoproteins, HDL / blood*
  • Lysophospholipids / blood*
  • Receptors, Lysosphingolipid / physiology
  • Sphingosine / analogs & derivatives*
  • Sphingosine / blood

Substances

  • Biomarkers
  • Lipoproteins, HDL
  • Lysophospholipids
  • Receptors, Lysosphingolipid
  • sphingosine 1-phosphate
  • Sphingosine